Algeria vs Gambia: Antiretroviral therapy coverage for PMTCT
Algeria
74.0%
in 2019
Gambia
77.0%
in 2024
Algeria rank
48th
Gambia rank
46th
Antiretroviral therapy coverage for PMTCT over time
- Algeria
- Gambia
How they compare
Gambia currently reports 77.0% against 74.0% in Algeria, a difference of 3.0%.
The two have swapped places 7 times across 20 shared years of data; in 2000 it was Gambia ahead.
Algeria ranks 48th and Gambia ranks 46th of 84 countries.
Gambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Algeria | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 11.6% | 4.7% | Gambia |
| 2010s | 52.5% | 63.1% | 10.6% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Algeria or Gambia?
- Gambia, at 77.0% against 74.0% in Algeria as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Algeria and Gambia?
- 3.0%, with Gambia ahead.
- How many years of comparable data are there for Algeria and Gambia?
- 20 years are reported by both, from 2000 to 2019.
- How do Algeria and Gambia rank globally for antiretroviral therapy coverage for pmtct?
- Algeria ranks 48th and Gambia ranks 46th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).